Chromophobe tumors account for < 5% of RCC tumors and typically show whole chromosome deletions, though the impact of these losses has not been fully characterized; mutations in PTEN and TP53 have been identified, but they are only present in a minority of cases (28, 29). This evidence concerns the gene PTEN and renal cell carcinoma.